Lupin Limited has informed the Exchange regarding a press release dated August 16, 2021, titled "Lupin Receives Tentative U.S. FDA Approval for Brivaracetam Tablets".
Lupin Limited has informed the Exchange regarding a press release dated August 16, 2021, titled "Lupin Receives Tentative U.S. FDA Approval for Brivaracetam Tablets".